Oncology & Cancer

Biomarker may aid in determining treatment for cancer patients

A common virus that is harmless to most individuals may produce an important biomarker in determining the prognosis of brain cancer patients, according to a recent study published by a student researcher at the University ...

Oncology & Cancer

A clear vision for cancer diagnosis

While reading an article about Sen. John McCain's glioblastoma diagnosis, Kavya Kopparapu was shocked to learn that the prognosis for this aggressive brain cancer has not improved over the past 30 years. With standard treatment, ...

Medications

Bevacizumab may cause cognitive impairment

Glioblastoma is the most common kind of brain tumour in adults. It is a very aggressive form of cancer; patients with this diagnosis have a median post-diagnosis survival of 15 months. Especially in the US, the drug Bevacizumab ...

Oncology & Cancer

Why some brain tumors respond to immunotherapy

Columbia researchers have learned why some glioblastomas—the most common type of brain cancer—respond to immunotherapy. The findings could help identify patients who are most likely to benefit from treatment with immunotherapy ...

Oncology & Cancer

Brain cancer survival has improved – but not much for elderly

A new study from Helsinki University Hospital, University of Helsinki and the Finnish Cancer Registry shows that survival after glioblastoma has improved since the millennium. The improvement in survival was, however, modest ...

page 4 from 5